← Back to Search

Use of risk prediction scores for Colorectal Adenomas (PREDICT Trial)

N/A

Waitlist Available

Led By Theodore R Levin, MD

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

PREDICT Trial Summary

This trial aims to develop a model to predict who is at risk of colorectal cancer based on their history, demographics & index colonoscopy. Now they are applying the model to help identify high-risk patients.

Eligible Conditions

Colorectal Adenomas
Colorectal Cancer

PREDICT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rates of colorectal neoplasia per number of colonoscopies performed

PREDICT Trial Design

1Treatment groups

Experimental Treatment

Group I: Use of risk prediction scoresExperimental Treatment1 Intervention

The prediction model is being used to identify patients who are at highest risk for colorectal cancer based on their risk scores.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The Permanente Medical GroupUNKNOWN

1 Previous Clinical Trials

2,091 Total Patients Enrolled

Kaiser PermanenteLead Sponsor

538 Previous Clinical Trials

24,113,093 Total Patients Enrolled

Theodore R Levin, MDPrincipal InvestigatorKaiser Permanente Northern California, Division of Research

2 Previous Clinical Trials

58,946 Total Patients Enrolled

1 Trials studying Colorectal Adenomas

8,946 Patients Enrolled for Colorectal Adenomas

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to enroll in this research program?

"This clinical trial seeks 720 individuals aged 18 to 85 that have been diagnosed with colorectal carcinoma. To meet the criteria, applicants must possess a hereditary syndrome related to this type of cancer (e.g., Lynch Syndrome); present positive results on diagnostic fecal immunochemical tests; require colonoscopies for screening purposes; hold an active place in the pending list for such procedure and not fall into those categories excluded from participation: having had a colonoscopy within 12 months or being voluntarily registered in a "pause" list."

Answered by AI

Is geriatric inclusion a factor in this research trial?

"This study is welcoming participants who are 18 and above, but below 85 years of age."

Answered by AI

Is this experiment actively enlisting participants at the moment?

"As of the latest update on November 3rd 2022, clinicaltrials.gov confirms that this specific medical study is at capacity and not presently recruiting patients. Fortunately, eleven hundred and thirty-five other trials are actively looking for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Predicting Risk for Post-polypectomy Colorectal Cancer

2022. "Predicting Risk for Post-polypectomy Colorectal Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05606081.